Is Unicycive Therapeutics, Inc. (UNCY) a Buy, Sell, or Hold?
NASDAQ : UNCY
Unicycive Therapeutics, Inc. — Analyst Ratings
$5.39 USD
$0.39 (7.8%)
- Volume
- 1.5M
- Average Volume
- 1.22M
- Market Capitalization
- $143.91M
- P/E Ratio
- -3.22
- Dividend Yield
- 0.00%
- Price Target
- $22.00
- Year High
- $8.74
- Year Low
- $3.71
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $3.81
Analyst Consensus Summary
Consensus Rating
Sell
8 Analysts
Rating Score
2/5
Recommendation Strength
Upside/Downside
-75.5%
vs Current Price
Price Target
$22.00
Average TargetPrice Target Range
Lowest Target
$22.00
-75.5% DOWNSIDE
Average Target
$22.00
Median Estimate
Highest Target
$22.00
-75.5% DOWNSIDEAnalyst Breakdown
Overall Consensus: Buy | Total Analysts: 8
| Strong Buy | Buy | Hold | Sell | Strong Sell |
|---|---|---|---|---|
| 0 | 8 | 0 | 0 | 0 |
Analyst Ratings (Detailed)
| Analyst Company | Analyst Name | Price Target | Price When Posted | Date | Upside/Downside |
|---|---|---|---|---|---|
| H.C. Wainwright | Swayampakula Ramakanth | $22 | $7.06 | 2026-05-27 06:50 AM | 211.6% |